Granulocyte-macrophage colony-stimulating factor activates the transcription of nuclear factor kappa B and induces the expression of nitric oxide synthase in a skin dendritic cell line

Immunology and Cell Biology

Volumn 79, Issue 6, 2001, Pages 590-596

  Cruz, M Teresa ^a,b   Duarte, Carlos B ^b   Gonçalo, Margarida ^c   Figueiredo, Américo ^c   Carvalho, Arsélio P ^b   Lopes, M Celeste ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

GM CSF; NF B; Nitric oxide; Nitric oxide synthase; Skin dendritic cell

Indexed keywords

BINDING PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOENZYME; NITRIC OXIDE SYNTHASE; NITRITE; PROTEIN P50; PROTEIN P52; PROTEIN SUBUNIT; PYRROLIDINE DITHIOCARBAMATE; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CELL LINE; CELL NUCLEUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DEGRADATION; DENDRITIC CELL; FETUS; IC 50; IMMUNOBLOTTING; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN TRANSPORT; SKIN CELL; TRANSCRIPTION REGULATION;

ANIMALS; ANTIOXIDANTS; CELL LINE; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE; PYRROLIDINES; SKIN; THIOCARBAMATES; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 0035176476     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2001.01041.x     Document Type: Article

References (43)

1. Dendritic cells and the control of immunity
2. Pathways of development of human dendritic cells
3. Nitric oxide: From discovery to the clinic
4. Biphasic effect of exogenous nitric oxide on proliferation and differentiation in skin derived keratinocytes but not fibroblasts
5. Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing
6. Enhanced collagen accumulation folowing direct transfection of the inducible nitric oxide synthase gene in cutaneous wounds
7. Langerhans cells may trigger the psoriatic disease via production of nitric oxide
8. Involvement of NO in contact hypersensitivity
9. Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses
10. Induction of nitric oxide synthase in mouse dendritic cells by IFN-γ, endotoxin, and interaction with allogeneic T cells. Nitric oxide production is associated with dendritic cell apoptosis
11. Langerhans cells express inducible nitric oxide synthase and produce nitric oxide
12. Involvement of JAK2 and MAPK on type II nitric oxide synthase expression in skin-derived dendritic cells
13. Regulation of DNA binding by Rel/NF-kB transcription factors: Structural views
14. Double-stranded RNA-induced inducible nitric-oxide synthase expression and interleukin-1 release by murine macrophages requires NF-kB activation
15. LPS induction of IkB-α degradation and iNOS expression in a skin dendritic cell line is prevented by the Janus kinase 2 inhibitor, tyrphostin B42
16. Establishment of a cell line with features of early dendritic cell precursors from fetal mouse skin
17. 15N]nitrate in biological fluids
18. Expression of inducible nitric oxide synthase by macrophages in rat lung
19. Phosphatidylserine is involved in the reduced rate of transcription of the inducible nitric oxide synthase gene in macrophages from tumor-bearing mice
20. Colony stimulating factors regulate nitric oxide and prostaglandin E2 production in rat cartilage chondrocytes
21. Murine epidermal Langerhans cells do not express inducible nitric oxide synthase
22. Role of transcription factor NF-kB/Rel in induction of nitric oxide synthase
23. Bcl-3 expression and nuclear translocation are induced by granulocyte-macrophage colony-stimulating factor and erythropoietin in proliferating human erythroid precursors
24. Roles of JAK kinases in human GM-CSF receptor signal transduction
25. Activation of c-Jun N-terminal kinase by human granulocyte macrophage-colony stimulating factor in BA/F3 cells
26. Activation of distinct transcription factors in neutrophils by bacterial LPS, interferon-γ, and GM-CSF and the necessity to overcome the action of endogenous proteases
27. Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophils. Involvement of Jak2 in the stimulation of phosphatidylinositol 3-kinase
28. Nuclear factor-kB to the rescue of cytokine-induced neuronal survival
29. Increased expression of p50-NF-kB and constitutive activation of NF-kB transcription factors during mouse skin carcinogenesis
30. It's got you covered: NF-kB in the epidermis
31. Differential expression of the transcription factor NF-kappaB during human mononuclear phagocyte differentiation to macrophages and dendritic cells
32. Dendritic cell survival and maturation are regulated by different signaling pathways
33. Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells
34. Vascular endothelial growth factor affects dendritic cell maturation through inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells
35. Expression of the RelB transcription factor correlates with the activation of human dendritic cells
36. Evidence for distinct intracellular signaling pathways in CD34+ progenitor to dendritic cell differentiation from a human cell line model
37. Nuclear localization of RelB is associated with effective antigen-presenting cell function
38. Expression of relB is required for the development of thymic medulla and dendritic cells
39. Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: Association with reduced nuclear translocation of nuclear factor kappa B
40. Comparative analysis of CD80 and CD86 on human Langerhans cells: Expression and function
41. Nitric oxide in human skin, current status and future prospects
42. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels
43. Nitric oxide inhibits the tumor necrosis factor alpha -regulated endocytosis of human dendritic cells in a cyclic GMP-dependent way